Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M105,644Revenue $M15,879Net Margin (%)12.6Z-Score5.7
Enterprise Value $M106,172EPS $1.2Operating Margin %16.3F-Score6
P/E(ttm))53.2Cash Flow Per Share $2.8Pre-tax Margin (%)15.0Higher ROA y-yN
Price/Book7.110-y EBITDA Growth Rate %-1.4Quick Ratio1.5Cash flow > EarningsY
Price/Sales6.75-y EBITDA Growth Rate %-14.3Current Ratio1.7Lower Leverage y-yY
Price/Cash Flow11.7y-y EBITDA Growth Rate %-21.1ROA % (ttm)5.8Higher Current Ratio y-yY
Dividend Yield %2.3Insider Buy (3m)0ROE % (ttm)13.2Less Shares Outstanding y-yN
Payout Ratio %121Shares Outstanding M1,662ROI % (ttm)5.7Gross Margin Increase y-yY

Gurus Latest Trades with BMY

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BMYVanguard Health Care Fund 2014-12-31 Add0.08%$48.92 - $61.3
($56.49)
$ 63.5611%Add 1.50%39,056,361
BMYIrving Kahn 2014-12-31 Add0.01%$48.92 - $61.3
($56.49)
$ 63.5611%Add 2.71%28,400
BMYDodge & Cox 2014-12-31 Add$48.92 - $61.3
($56.49)
$ 63.5611%Add 0.66%91,028
BMYMario Gabelli 2014-12-31 Add$48.92 - $61.3
($56.49)
$ 63.5611%Add 1.35%709,715
BMYRonald Muhlenkamp 2014-12-31 Reduce$48.92 - $61.3
($56.49)
$ 63.5611%Reduce -0.09%212,290
BMYRuane Cunniff 2014-12-31 Buy $48.92 - $61.3
($56.53)
$ 63.5611%New holding3,670
BMYKen Fisher 2014-12-31 Reduce$48.92 - $61.3
($56.42)
$ 63.5611%Reduce -39.96%30,739
BMYRay Dalio 2014-12-31 Sold Out $48.92 - $61.3
($56.42)
$ 63.5611%Sold Out0
BMYVanguard Health Care Fund 2014-09-30 Add0.3%$47.86 - $51.96
($49.97)
$ 63.5621%Add 6.31%38,480,761
BMYJoel Greenblatt 2014-09-30 Sold Out -0.05%$47.86 - $51.96
($49.97)
$ 63.5621%Sold Out0
BMYRay Dalio 2014-09-30 Buy $47.86 - $51.96
($49.97)
$ 63.5621%New holding10,228
BMYVanguard Health Care Fund 2014-06-30 Add0.86%$46.59 - $52.19
($49.29)
$ 63.5622%Add 22.96%36,197,961
BMYJoel Greenblatt 2014-06-30 Buy 0.05%$46.59 - $52.19
($49.29)
$ 63.5622%New holding89,363
BMYKen Fisher 2014-06-30 Add$46.59 - $52.19
($49.29)
$ 63.5622%Add 216.10%49,732
BMYRay Dalio 2014-06-30 Sold Out $46.59 - $52.19
($49.29)
$ 63.5622%Sold Out0
BMYRonald Muhlenkamp 2014-03-31 Buy 1.9%$48.54 - $56.61
($53.23)
$ 63.5616%New holding212,015
BMYVanguard Health Care Fund 2014-03-31 Add0.73%$48.54 - $56.61
($53.21)
$ 63.5616%Add 20.35%29,437,761
BMYGeorge Soros 2014-03-31 Sold Out -0.05%$48.54 - $56.61
($53.23)
$ 63.5616%Sold Out0
BMYJoel Greenblatt 2014-03-31 Sold Out -0.02%$48.54 - $56.61
($53.23)
$ 63.5616%Sold Out0
BMYRay Dalio 2014-03-31 Buy $48.54 - $56.61
($53.23)
$ 63.5616%New holding4,428
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BMY is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


BMY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Schmukler Louis SPres., Global Mfg. & Supply 2015-03-16Sell12,000$66.96-2.93view
Cuss Francis MEVP & CSO 2015-03-16Sell114,666$67.81-4.14view
Moed Samuel JSVP, Strat Plan & Analysis 2015-03-13Sell591$66.67-2.5view
Moed Samuel JSVP, Strat Plan & Analysis 2015-03-10Sell10,343$65.84-1.28view
Elicker John ESVP Pub Affairs & Inv Relation 2015-03-06Sell10,468$66.24-1.87view
LEUNG SANDRAGeneral Counsel & Secretary 2015-02-17Sell11,746$60.397.63view
Moed Samuel JSVP, Strat Plan & Analysis 2015-02-12Sell3,880$59.269.69view
Moed Samuel JSVP, Strat Plan & Analysis 2015-02-06Sell21,478$60.158.06view
CORNELIUS JAMES MDirector 2015-01-30Sell50,000$60.67.26view
Schmukler Louis SPres., Global Mfg. & Supply 2015-01-29Sell5,250$60.737.03view

Press Releases about BMY :

    Quarterly/Annual Reports about BMY:

    News about BMY:

    Articles On GuruFocus.com
    Weekly Insider Sells Highlight: MHK, JAZZ, BMY, ZAYO Mar 23 2015 
    Top Pharma Stock Picks For March Mar 13 2015 
    Johnson & Johnson Unfazed By $25 Million Fine Mar 13 2015 
    Bayer Goes Into Disinvestment Mode Due To Falling Profit Numbers Feb 27 2015 
    Abner Herrman's Top Three Holdings Feb 26 2015 
    Biocept (BIOC) Soars on Liquid Biopsy Appreciation, Rigel Pharmaceuticals (RIGL) Mega-deal with Bris Feb 23 2015 
    Pharmaceuticals Sector To See High Voltage Action in 2015 Jan 23 2015 
    Feeling Good With This Med Company Jan 20 2015 
    mom Dec 27 2014 
    I think Zimmer Will Outperform S&P 500 Performance Dec 04 2014 

    More From Our Partners
    Merck in $10B Buyback; Keytruda Tops Melanoma Study - Analyst Blog Mar 26 2015 - ZACKS

    More From Other Websites
    Final Glance: Pharmaceuticals companies Mar 26 2015
    Final Glance: Pharmaceuticals companies Mar 26 2015
    Midday Glance: Pharmaceuticals companies Mar 26 2015
    Midday Glance: Pharmaceuticals companies Mar 26 2015
    Healthcare Hedge Fund Orbimed’s Top Picks and New Move Mar 26 2015
    Early Glance: Pharmaceuticals companies Mar 26 2015
    Early Glance: Pharmaceuticals companies Mar 26 2015
    Merck in $10B Buyback; Keytruda Tops Melanoma Study - Analyst Blog Mar 26 2015
    Science, patients driving rare disease drug research surge Mar 25 2015
    Science, patients driving rare disease drug research surge Mar 25 2015
    Merck halts study in light of melanoma drug’s success Mar 24 2015
    Hottest dividend stocks of 2015 Mar 24 2015
    Two Healthcare Stocks Provide Antidotes To Wild Market Swings Mar 24 2015
    Merck's Keytruda Bests Yervoy In Early Melanoma Mar 24 2015
    Merck says melanoma drug meets goal; study halted Mar 24 2015
    Bristol-Myers Squibb (BMY) Stock Price Target Increased at BMO Mar 24 2015
    Bristol-Myers buys rights to Novo Nordisk immune system project Mar 24 2015
    Bristol-Myers Squibb Acquires Exclusive License from Novo Nordisk for a Discovery Research Program... Mar 24 2015
    Bristol-Myers Squibb Acquires Exclusive License from Novo Nordisk for a Discovery Research Program... Mar 24 2015
    11 Promising New Drugs Expected to Make Billions in Sales Mar 23 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK